4 unknown, 3 recruiting, 1 suspended. 7 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 3, Unknown 3, Suspended 1 |
| Phase 1 | 6 | Unknown 4, Recruiting 2 |
Follow ImmVira Pharma Co. Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/IIa Study of C5252 in Patients With Intracranial Tumor Herpes Virus C5252 Injection - Glioma, Malignant | Phase 1 / Phase 2 | Recruiting | ImmVira Pharma Co. Ltd | 36 | 2026-04-03 | 2026-08-17 |
| A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC T3011 - Nonmuscle-invasive Bladder Cancer | Phase 2 | Recruiting | ImmVira Pharma Co. Ltd | 160 | 2025-06-09 | 2026-08-18 |
| T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma T3011 + Cobimetinib - Melanoma, Malignant Melanoma | Phase 2 | Suspended | ImmVira Pharma Co. Ltd | 68 | 2024-06-30 | 2024-02-01 |
| A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma C5252 - Solid Tumor, Glioblastoma | Phase 1 | Unknown | ImmVira Pharma Co. Ltd | 51 | 2023-03-15 | 2022-10-12 |
| A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. T3011 - Advanced Solid Tumor, Lung Cancer | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 74 | 2022-03-01 | 2022-10-28 |
| Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors T3011 - Solid Tumor, Hepatocellular Carcinoma | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 42 | 2021-08-10 | 2024-03-04 |
| A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors T3011, T3011 + pembrolizumab - Solid Tumor, Melanoma | Phase 1 / Phase 2 | Recruiting | ImmVira Pharma Co. Ltd | 30 | 2020-09-17 | 2025-10-08 |
| A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors T3011 - Advanced Solid Tumor, Sarcoma | Phase 1 / Phase 2 | Unknown | ImmVira Pharma Co. Ltd | 233 | 2020-04-21 | 2022-11-02 |
Melanoma (2) · Sarcoma (2) · Squamous Cell Carcinoma of Head and Neck (2) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Liver Neoplasms (1) · Lung Neoplasms (1) · Lymphoma (1) · Mesothelioma, Malignant (1)
cobimetinib (1) · pembrolizumab (1)
United States (5) · China (3) · Australia (1)